• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

COHR changes management team

Article

Embattled independent service organization COHR of Chatsworth, CA, made major changes to its management team this month. The moves included the departure of long-time COHR executive Sandy Morford, who was the target of a critical article on COHR's

Embattled independent service organization COHR of Chatsworth, CA, made major changes to its management team this month. The moves included the departure of long-time COHR executive Sandy Morford, who was the target of a critical article on COHR's business practices published in April in financial newspaper Barron's (SCAN 4/29/98).

COHR reported that Morford, formerly COO, and Haresh Satiani, formerly senior vice president of the company's Maintenance MasterPlan program, have left the firm. New additions to COHR's executive suites include Raymond List as president and CEO and Peter Socha as executive vice president.

The Barron's article accused COHR and Morford of accounting irregularities in running the MasterPlan program, which provides hospitals with equipment maintenance at a fixed price. The program guarantees rebates to hospitals if their spending is below the fixed price, but the Barron's article alleged that COHR pocketed some of those rebates rather than returning them to customers.

COHR denied the allegations in a press release issued after the article was published. The revelations have resulted in a raft of shareholder lawsuits against the company, which has put itself on the block as an acquisition candidate.

Recent Videos
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Can 18F-Floutufolastat Bolster Detection of PCa Recurrence in Patients with Low PSA Levels After Radical Prostatectomy?
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.